Strides Sells Australian Business To Arrow-Apotex Merger
Strides Pharma Science has agreed to sell its entire Australian business, including its local Arrow unit, to the Arrow-Apotex merged entity known as ‘Arrotex’, as the firm concentrates its efforts in the US and Canada.
You may also be interested in...
In the third and final part of Generics Bulletin’s newly-compiled global sales ranking of generics and biosimilars companies, one or two new entrants appeared towards the bottom of the top 50.
Strides Pharma Science has acquired a majority stake in Swiss generics firm Fairmed Healthcare in a move to bolster its presence in central Europe. The acquisition marks the latest in a string of transactions by the Indian firm.
India's Strides has bought a Florida soft-gel capsule manufacturing plant for $500,000 and plans to pump in up to $10m in investment to build capacity and add dosage formats.